What was Profusa, Inc.'s revenue in Q3 FY2024?

Profusa, Inc. reported total revenue of $75.0K in Q3 FY2024.

What was Profusa, Inc.'s net profit in Q3 FY2024?

Profusa, Inc. reported net profit of $-2.5M in Q3 FY2024, a net margin of -3329.3%.

What were Profusa, Inc.'s margins in Q3 FY2024?

Profusa, Inc. had operating margin of -1470.7% in Q3 FY2024.

What was Profusa, Inc.'s EPS in Q3 FY2024?

Profusa, Inc. reported diluted EPS of $-1.29 in Q3 FY2024.

Profusa, Inc.PFSAEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

Deep Analysis

Profusa, Inc. is a biotechnology firm specializing in long-term implantable biosensor technology. Its products enable continuous real-time monitoring of multiple biological markers, serving core segments including clinical care, chronic disease management, medical research, and global digital health markets.

Q3 2024

Revenue

$75.0K

Gross Profit

N/A

Operating Profit

$-1.1M

Net Profit

$-2.5M

Gross Margin

N/A

Operating Margin

-1470.7%

Net Margin

-3329.3%

YoY Growth

N/A

EPS

$-1.29

Profusa, Inc. Q3 FY2024 Financial Summary

Profusa, Inc. reported revenue of $75.0K for Q3 FY2024, with a net profit of $-2.5M (down 579.7% YoY) (-3329.3% margin).

Key Financial Metrics

Total Revenue	$75.0K
Net Profit	$-2.5M
Gross Margin	N/A
Operating Margin	-1470.7%
Report Period	Q3 FY2024

Income Statement

	Q3 2024
Revenue	$75000
YoY Growth	N/A

Balance Sheet

	Q3 2024
Assets	$8.8M
Liabilities	$5.8M
Equity	$-117.0M

Cash Flow

	Q3 2024
Operating CF	$-1.2M